Results 41 to 50 of about 1,231,799 (291)

Epidemic dynamics in finite size scale-free networks [PDF]

, 2002
Many real networks present a bounded scale-free behavior with a connectivity cut-off due to physical constraints or a finite network size. We study epidemic dynamics in bounded scale-free networks with soft and hard connectivity cut-offs. The finite size
A.-L. Barabási, Alessandro Vespignani, D. J. Watts, F. Liljeros, G. Caldarelli, H. W. Hethcote, L. A. N. Amaral, M. Faloutsos, R. Albert, R. Albert, R. M. May, R. Pastor-Satorras, R. Pastor-Satorras, R. Pastor-Satorras, Romualdo Pastor-Satorras, S. H. Strogatz   +15 more
core   +3 more sources

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

Advanced Healthcare Materials, EarlyView.
Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang, Jingguo Qu, Tonghuan Xiao, Xinyang Han, Michael Tin‐Cheung Ying   +4 more
wiley   +1 more source

Informed decisions about public health and social measures

Health Research Policy and Systems
Evidence, communication, critical thinking and participation are the cornerstones of informed decisions. In this article we discuss each of these in relation to decisions about public health and social measures (PHSM) during the coronavirus disease 2019 (
Andrew D. Oxman, Annlaug Selstø, Arnfinn Helleve, Atle Fretheim, Cathinka Halle Julin, Christine Holst, Christopher James Rose, Heather Munthe-Kaas, Ingeborg Hess Elgersma, Jenny Moberg, Mona Bjørbæk, Petter Elstrøm, Runar Barstad Solberg, Sarah E. Rosenbaum, Signe Flottorp, Tone Bruun, Unni Gopinathan   +16 more
doaj   +1 more source

A Background of the Opioid Epidemic and Its Relationship to the Medicaid Expansion [PDF]

, 2019
Despite the recent increase in public awareness of the opioid epidemic, the background of this epidemic is still disappointingly unknown to the public.
Jang, Er Yearn
core   +2 more sources

From Lab to Landscape: Environmental Biohybrid Robotics for Ecological Futures

Advanced Robotics Research, EarlyView.
This Perspective explores environmental biohybrid robotics, integrating living tissues, microorganisms, and insects for operation in real‐world ecosystems. It traces the leap from laboratory experiments to forests, wetlands, and urban environments and discusses key challenges, development pathways, and opportunities for ecological monitoring and ...
Miriam Filippi
wiley   +1 more source

Contextual Insights for Infectious Pathogen Surveillance Using the Epidemic Intelligence from Open Sources System

Annals of Global Health
Background: Surveillance systems with early warning alert and response (EWAR) objectives often integrate diverse data sources, including laboratory surveillance, community reports, and open-source information for robust public health intelligence.
Farah Kader, Raquel Medialdea Carrera, Carolyn Briody, Julie Fontaine, Yeon Kyeng Lee, Johannes Schnitzler, Philip AbdelMalik   +6 more
doaj   +1 more source

Marburg Virus Glycoprotein Is a Remarkable Virulent Factor Linked to Hemorrhagic Pathology: Evidence from Multimodal Experimental Systems

Advanced Science, EarlyView.
By integrating data from in vitro, ex vivo, and in vivo models, our research identifies the MARV glycoprotein as a remarkable hemorrhagic factor, filling a major gap in this important field. It also provides practical experimental tools for the basic research on viral pathogenesis and applied research aimed at antiviral intervention for hemorrhagic ...
Ting Yao, Hang Liu, Yanfeng Yao, Wei Deng, Jiawen Sun, Zhenyu Kang, Ashaq Ali, Chao Shan, Zhiming Yuan, Fei Deng, Hualin Wang, Yun‐Jia Ning   +11 more
wiley   +1 more source

Why were so few randomized trials of public health and social measures conducted during the COVID-19 pandemic? The Norwegian experience

Trials
Background Few randomized trials of public health and social measures were carried out during the COVID-19 pandemic. We report on the major barriers we faced when we tried to run such trials.
Atle Fretheim, Petter Elstrøm, Cathinka Halle Julin, Unni Gopinathan, Ingeborg Hess Elgersma, Runar Barstad Solberg, Arnfinn Helleve   +6 more
doaj   +1 more source

Lymphoid‐Tissue‐on‐Chip Recapitulates Human Antibody Responses In Vitro

Advanced Science, EarlyView.
The presented lymphoid‐tissue‐on‐chip system allows culture of primary human tonsil cells at organotypic high density under perfusion for up to 4 weeks, emulates immune response to soluble vaccines and vaccination via peripheral antigen‐presenting cells and represents a useful tool to assess cellular interactions during homeostasis, immune responses ...
Claudia Teufel, Anna‐Sophie Schlemmer, Andrea W. Eiken, Zachary W. Wagoner, Dennis Vöhringer, Lena Christ, Alex Dulovic, Patrick Marsall, Madeleine Fandrich, Eduardo J. S. Brás, Julia Marzi, Friederike Bärhold, Julia Philipp, Sven Becker, Lisa E. Wagar, Peter Loskill   +15 more
wiley   +1 more source

Machine‐Learning Microfluidic Minute‐Scale Microorganism Metrics Monitoring(M6)

Advanced Science, EarlyView.
ABSTRACT On‐site monitoring of microorganisms remains challenging because of low concentrations, strong background interference, and dynamic aerosol diffusion, particularly for aerosol‐transmitted pathogens. Here, we report a rapid detection platform that integrates a Puri‐focusing microfluidic chip, electrochemical impedance spectroscopy (EIS), and ...
Ning Yang, Jiahao Ding, Si Chen, Lijie Yan, Shichao Ding, Lavonda Li, Junyi Sun, Haodong Liu, Tongge Li, Ning Liu, Mingji Wei, Xiaoyong Zhu, Xiaobo Zou, Shouqi Yuan, Xingcai Zhang   +14 more
wiley   +1 more source